← Eichor
Study identifier: NCT06771011 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective Comparative Validation Study of RUCAM and RECAM

Condition: Drug Induced Liver Injury  ·  Sponsor: Beijing Friendship Hospital

PhaseN/A
Planned participants407
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

A total of 407 hospitalized patients with acute liver injury in Beijing Friendship Hospital Affiliated to Capital Medical University were enrolled. The clinical information, biochemical examination, imageological examination (ultrasound, CT, MRI) and liver biopsy pathology of patients with acute liver injury will be collected. The diagnostic efficacy of RECAM and RUCAM in the diagnosis of DILI will be compared, and the consistency of different clinicians in the diagnosis of DILI using RECAM and RUCAM scores will also be compared.

This description comes directly from the study's public registry record.

Talk to the study team

Xinyan Zhao  ·  13801001732  ·  zhao_xinyan@ccmu.edu.cn

Yao Meng  ·  13011670736  ·  mengyao2954@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing Friendship HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06771011